Syros Pharmaceuticals Cash from Financing (TTM) Trends

Syros Pharmaceuticals Inc (SYRS)

5.37 -0.01 (-0.19%) USD | NASDAQ | Apr 30, 16:00

5.38 +0.01 (+0.19%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	43.46M
September 30, 2023	-10.62M
June 30, 2023	131.45M
March 31, 2023	131.08M
December 31, 2022	131.04M
September 30, 2022	141.84M
June 30, 2022	-0.287M
March 31, 2022	0.008M
December 31, 2021	70.51M
September 30, 2021	181.22M
June 30, 2021	181.52M
March 31, 2021	181.67M
December 31, 2020	142.95M
September 30, 2020	33.24M
June 30, 2020	32.99M
March 31, 2020	97.80M
December 31, 2019	65.99M

Date	Value
September 30, 2019	65.04M
June 30, 2019	65.38M
March 31, 2019	16.80M
December 31, 2018	69.08M
September 30, 2018	69.64M
June 30, 2018	69.28M
March 31, 2018	85.98M
December 31, 2017	33.94M
September 30, 2017	33.27M
June 30, 2017	86.03M
March 31, 2017	52.32M
December 31, 2016	90.56M
September 30, 2016	89.95M
June 30, 2016	37.20M
March 31, 2016	38.09M
December 31, 2015	-0.278M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-10.62M

Minimum

Sep 2023

181.67M

Maximum

Mar 2021

88.75M

Average

70.51M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks